Guardian Pharmacy Services GRDN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 20.9%+0.7pp | 20.2%+0.5pp | 19.7%+0.1pp | 19.6%-0.1pp | 19.8%-0.1pp | |
| Operating margin | 5.3%+0.3pp | 5%— | —— | —— | —— | |
| Net margin | 3.6%+0.2pp | 3.4%+1.4pp | 2%+9.8pp | -7.8%+1.0pp | -8.8%+0.6pp | |
| Returns | ||||||
| Return on equity | 26.8%+0.1pp | 26.8%— | —— | —— | —— | |
| Return on invested capital | 27.4%+1.9pp | 25.5%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 3.8×-0.1× | 4×+0.2× | 3.8×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 1.5×+0.1× | 1.4×+0.2× | 1.2×0.0× | 1.2×0.0× | 1.1×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×— | —— | —— | 0.2×-0.1× | |
| Net debt / EBITDA | -0.3×-0.1× | -0.2×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $3.65+6.0% | $3.44— | —— | —— | $2.59+7.3% | |
| Valuation | ||||||
| Market capitalization | $2.42B+27.2% | $1.91B+14.7% | $1.66B+27.4% | $1.3B-3.1% | $1.35B+4.9% | |
| Price / earnings | 45.7×+7.0× | 38.7×-20.0× | 58.7×— | —— | —— | |
| Price / sales | 1.7×+0.3× | 1.3×+0.1× | 1.2×+0.2× | 1×-0.1× | 1×0.0× | |
| Price / book | 10.4×+1.7× | 8.7×— | —— | —— | 8.2×-0.3× | |
| EV / EBITDA | 23.9×+4.0× | 19.8×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardian Pharmacy Services's profit margins?
- Guardian Pharmacy Services (GRDN) runs a 20.9% gross margin and a 5.3% operating margin, with a 3.6% net margin.
- Where do Guardian Pharmacy Services's ratios come from?
- Every ratio is computed from Guardian Pharmacy Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
